Annual EBITDA
$3.26B$400.00M+13.97%
Summary
- Current Value
- As of today, CAH annual EBITDA is $3.26B, up +13.97% on
- Historical Performance
- CAH annual EBITDA is up +36.19% over the past 3 years, and up +20.94% over the past 5 years
- All-Time High Comparison
- CAH annual EBITDA is currently -8.24% below its historical high of $3.56B set on
- 3-Year Low Comparison
- CAH annual EBITDA is +36.19% above its 3-year low of $2.40B reached on an earlier date
- Sector Comparison
- CAH annual EBITDA is higher than 96.94% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.26B | +14.0% | +36.2% | +20.9% | +100.7% | |
| Quarterly EBITDA | $1.00B | +35.9% | +94.2% | +50.3% | +122.2% | |
| TTM EBITDA | $3.63B | +23.6% | +59.9% | +34.7% | +113.0% | |
| Price | $201.11 | +64.1% | +159.3% | +259.7% | +418.3% | |
| PE Ratio | 30.36 | +33.0% | – | +154.7% | +109.7% | |
| Annual Revenue | $222.58B | -1.9% | +22.7% | +45.5% | +126.0% | |
| Annual EPS | $6.45 | +87.0% | +292.9% | +151.1% | +263.0% | |
| Annual EBIT | $2.79B | +29.4% | +66.5% | +56.4% | +101.7% | |
| Annual Net Income | $1.57B | +83.9% | +268.4% | +142.5% | +167.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.26B | at high | |
| 5Y | $3.26B | at high | |
| All | $3.56B | -8.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.40B | N/A | +36.2% |
| 5Y | $2.40B | +36.2% | |
| All | $4.10M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of CAH?
As of today, CAH annual EBITDA is $3.26B
What is 1-year change in CAH annual EBITDA?
CAH annual EBITDA is up +13.97% year-over-year
What is 3-year change in CAH annual EBITDA?
CAH annual EBITDA is up +36.19% over the past 3 years
How far is CAH annual EBITDA from its all-time high?
CAH annual EBITDA is currently -8.24% below its historical high of $3.56B set on June 30, 2018
How does CAH annual EBITDA rank versus sector peers?
CAH annual EBITDA is higher than 96.94% of companies in Healthcare sector
When is CAH next annual earnings release?
As of today, the next annual earnings release for CAH has not been scheduled
Quarterly EBITDA
$1.00B$77.00M+8.31%
Summary
- Current Value
- As of today, CAH quarterly EBITDA is $1.00B, up +8.31% on
- Historical Performance
- CAH quarterly EBITDA is up +35.86% year-over-year, and up +94.20% over the past 3 years
- All-Time High Comparison
- CAH quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH quarterly EBITDA is +75.83% above its 3-year low of $571.00M reached on an earlier date
- Sector Comparison
- CAH quarterly EBITDA is higher than 96.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.00B | +8.3% | +35.9% | +94.2% | +50.3% | |
| Annual EBITDA | $3.26B | – | +14.0% | +36.2% | +20.9% | |
| TTM EBITDA | $3.63B | +7.9% | +23.6% | +59.9% | +34.7% | |
| Price | $201.11 | +27.9% | +64.1% | +159.3% | +259.7% | |
| PE Ratio | 30.36 | +27.9% | +33.0% | – | +154.7% | |
| Quarterly Revenue | $64.01B | +6.4% | +22.4% | +29.0% | +63.9% | |
| Quarterly EPS | $1.88 | +89.1% | +10.9% | +367.3% | +318.0% | |
| Quarterly EBIT | $771.00M | +7.4% | +38.4% | +122.8% | +66.5% | |
| Quarterly Net Income | $454.00M | +86.8% | +8.9% | +309.0% | +279.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.00B | at high | |
| 3Y | $1.00B | at high | |
| 5Y | $1.00B | at high | |
| All | $1.00B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $758.00M | N/A | +32.5% |
| 3Y | $571.00M | N/A | +75.8% |
| 5Y | $435.00M | +130.8% | |
| All | -$484.00M | +307.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CAH?
As of today, CAH quarterly EBITDA is $1.00B
What is CAH quarterly EBITDA most recent change?
CAH quarterly EBITDA was up +8.31% on September 30, 2025
What is 1-year change in CAH quarterly EBITDA?
CAH quarterly EBITDA is up +35.86% year-over-year
How far is CAH quarterly EBITDA from its all-time high?
CAH quarterly EBITDA is currently at its all-time high
How does CAH quarterly EBITDA rank versus sector peers?
CAH quarterly EBITDA is higher than 96.84% of companies in Healthcare sector
When is CAH next earnings release?
The next earnings release for CAH is on
TTM EBITDA
$3.63B$265.00M+7.88%
Summary
- Current Value
- As of today, CAH TTM EBITDA is $3.63B, up +7.88% on
- Historical Performance
- CAH TTM EBITDA is up +23.62% year-over-year, and up +59.92% over the past 3 years
- All-Time High Comparison
- CAH TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CAH TTM EBITDA is +58.45% above its 3-year low of $2.29B reached on an earlier date
- Sector Comparison
- CAH TTM EBITDA is higher than 96.84% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $3.63B | +7.9% | +23.6% | +59.9% | +34.7% | |
| Annual EBITDA | $3.26B | – | +14.0% | +36.2% | +20.9% | |
| Quarterly EBITDA | $1.00B | +8.3% | +35.9% | +94.2% | +50.3% | |
| Price | $201.11 | +27.9% | +64.1% | +159.3% | +259.7% | |
| PE Ratio | 30.36 | +27.9% | +33.0% | – | +154.7% | |
| TTM Revenue | $234.31B | +5.3% | +4.4% | +25.3% | +51.5% | |
| TTM EPS | $6.62 | +2.9% | +26.9% | +266.5% | +100.3% | |
| TTM EBIT | $2.79B | +8.3% | +25.8% | +77.1% | +54.4% | |
| TTM Net Income | $1.61B | +2.4% | +25.4% | +246.9% | +64.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.63B | at high | |
| 3Y | $3.63B | at high | |
| 5Y | $3.63B | at high | |
| All | $3.63B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.99B | N/A | +21.1% |
| 3Y | $2.29B | N/A | +58.5% |
| 5Y | $2.27B | +59.9% | |
| All | -$96.20M | +3870.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CAH?
As of today, CAH TTM EBITDA is $3.63B
What is CAH TTM EBITDA most recent change?
CAH TTM EBITDA was up +7.88% on September 30, 2025
What is 1-year change in CAH TTM EBITDA?
CAH TTM EBITDA is up +23.62% year-over-year
How far is CAH TTM EBITDA from its all-time high?
CAH TTM EBITDA is currently at its all-time high
How does CAH TTM EBITDA rank versus sector peers?
CAH TTM EBITDA is higher than 96.84% of companies in Healthcare sector
When is CAH next earnings release?
The next earnings release for CAH is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- CAH Official Website www.cardinalhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/721371/000072137125000122/0000721371-25-000122-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/721371/000072137125000079/0000721371-25-000079-index.htm
- CAH Profile on Yahoo Finance finance.yahoo.com/quote/CAH
- CAH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cah